Dasatinib suppresses in vitro natural killer cell cytotoxicity

被引：67

作者：

Blake, Stephen J. ^{[1
]}

Lyons, A. Bruce ^{[1
]}

Fraser, Cara K. ^{[1
]}

Hayball, John D. ^{[1
]}

Hughes, Timothy R. ^{[1
]}

机构：

[1] Inst Med & Vet Sci, Adelaide, SA 5000, Australia

来源：

BLOOD | 2008年 / 111卷 / 08期

关键词：

D O I：

10.1182/blood-2008-02-138701

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4415 / 4416

页数：2

共 11 条

[1] Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy [J].

Hochhaus, Andreas ;

Kantarjian, Hagop M. ;

Baccarani, Michele ;

Lipton, Jeffrey H. ;

Apperley, Jane F. ;

Druker, Brian J. ;

Facon, Thierry ;

Goldberg, Stuart L. ;

Cervantes, Francisco ;

Niederwieser, Dietger ;

Silver, Richard T. ;

Stone, Richard M. ;

Hughes, Timothy P. ;

Muller, Martin C. ;

Ezzeddine, Rana ;

Countouriotis, Athena M. ;

Shah, Neil P. .

BLOOD, 2007, 109 (06) :2303-2309

[2] A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells [J].

Höppner, M ;

Luhm, J ;

Schlenke, P ;

Koritke, P ;

Frohn, C .

JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 267 (02) :157-163

[3]

Lowin-Kropf B, 2002, EUR J IMMUNOL, V32, P773, DOI 10.1002/1521-4141(200203)32:3<773::AID-IMMU773>3.0.CO

[4]

2-U

[5] DETERMINATION OF LYMPHOCYTE DIVISION BY FLOW-CYTOMETRY [J].

LYONS, AB ;

PARISH, CR .

JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 171 (01) :131-137

[6]

PIGNATA C, 1993, J IMMUNOL, V151, P6794

[7] Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation [J].

Schade, Andrew E. ;

Schieven, Gary L. ;

Townsend, Robert ;

Jankowska, Anna M. ;

Susulic, Vojkan ;

Zhang, Rosemary ;

Szpurka, Hadrian ;

Maciejewski, Jaroslaw P. .

BLOOD, 2008, 111 (03) :1366-1377

[8] Overriding imatinib resistance with a novel ABL kinase inhibitor [J].

Shah, NP ;

Tran, C ;

Lee, FY ;

Chen, P ;

Norris, D ;

Sawyers, CL .

SCIENCE, 2004, 305 (5682) :399-401

[9]

Tabiasco J, 2002, EUR J IMMUNOL, V32, P1502, DOI 10.1002/1521-4141(200205)32:5<1502::AID-IMMU1502>3.0.CO

[10]

2-Y

← 1 2 →